Blog
RSS FeedPosted by Michael Wonder on 25 Oct 2017
U.S. lawmakers will not tackle healthcare this year, Ryan says
26 October 2017 - Republican lawmakers will not take up a bipartisan plan to stabilise Obamacare insurance markets or try again ...
Posted by Michael Wonder on 25 Oct 2017
Mr. Quixote goes to Washington? A bill would allow Medicare to negotiate drug prices.
25 October 2017 - In what some may call a quixotic move, a group of Democratic lawmakers on Wednesday will ...
Posted by Michael Wonder on 25 Oct 2017
Institute for Clinical and Economic Review opens nominations for new members of its voting panels
26 October 2017 - Independent panel members debate the evidence on the effectiveness and value of new drugs and other health ...
Posted by Michael Wonder on 25 Oct 2017
Medivir receives FDA fast track designation for MIV-711 for the treatment of osteoarthritis
24 October 2017 - Medivir today announced that the U.S. FDA has granted fast track designation for the company´s product ...
Posted by Michael Wonder on 24 Oct 2017
FDA grants fast track designation to Alzheon’s ALZ-801 development program for the treatment of Alzheimer’s disease
24 October 2017 - Company’s phase 3 clinical program pioneers a precision medicine approach in Alzheimer’s disease. ...
Posted by Michael Wonder on 24 Oct 2017
We need to remove barriers for high-cost cancer drugs
24 October 2017 - Imagine being the parent of a child suffering from leukemia. All conventional treatments have failed; the ...
Posted by Michael Wonder on 24 Oct 2017
Medical device development tools: helping to speed medical device evaluation and approval
24 October 2017 - The FDA relies on sound science in its decision-making, which provides medical device innovators with a ...
Posted by Michael Wonder on 24 Oct 2017
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance medical device innovation and help patients gain faster access to beneficial technologies
24 October 2017 - Enabling patients and providers to have efficient access to new and innovative medical products that meet ...
Posted by Michael Wonder on 24 Oct 2017
California just passed a law to rein in drug prices. Here’s why it’s unlikely to make much difference.
24 October 2017 - Over bitter protests from the pharmaceutical industry, California this month enacted a law that requires drug ...
Posted by Michael Wonder on 24 Oct 2017
Top Celgene cancer drugs now 20% more expensive after latest price hikes
23 October 2017 - Blockbuster drugs Revlimid and Pomalyst are Celgene’s two most valuable products — now especially so. ...
Posted by Michael Wonder on 24 Oct 2017
FDA approves Soliris (eculizumab) for the treatment of patients with generalised myasthenia gravis
23 October 2017 - First FDA approved treatment in more than 60 years for patients with generalised myasthenia gravis, a ...
Posted by Michael Wonder on 24 Oct 2017
US FDA approves new easy-to-use, once-weekly Bydureon BCise injectable medicine for patients with type 2 diabetes
23 October 2017 - New formulation of once-weekly exenatide in an improved device provides significant HbA1c reduction with added benefit ...
Posted by Michael Wonder on 24 Oct 2017
United Therapeutics announces FDA approval of third generation nebuliser for the Tyvaso inhalation system
23 October 2017 - United Therapeutics today announced approval by the U.S. FDA of a new inhalation device, called the ...
Posted by Michael Wonder on 23 Oct 2017
Health and wealth in the United States and England—two very different countries with similar findings
23 October 2017 - Although superficially they have much in common, health and social policy in the United States and England ...
Posted by Michael Wonder on 23 Oct 2017
Novartis combination adjuvant therapy Tafinlar and Mekinist receives FDA breakthrough therapy designation for stage III BRAF V600 mutation-positive melanoma patients
23 October 2017 - First targeted combination therapy to demonstrate a clinical benefit in patients with a BRAF V600E/K mutation in ...